Active

Molbio Diagnostics Limited

Molbio Diagnostics Limited IPO Details

Listing Date

-

Bid Price

₹0 - ₹0

Lot Size

0 Shares

Minimum Investment

Issue Size

₹0 Cr

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

-

tick

Offer End Date

-

tick

Allotment Date

-

tick

Refund Initiation

-

tick

Demat Transfer

-

tick

Listing Date

-

Molbio Diagnostics Limited Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 0% 0%
Public Group 100% 100%

Molbio Diagnostics Limited IPO Reservation

QIB Shares Offered 0 (0%)
NII (HNI) Shares Offered 0 (0%)
Retail Shares Offered 0 (0%)
Anchor Investor Shares Offered 0 (0%)
Total Shares Offered 0
Total Shares With Anchor Investor 0

Molbio Diagnostics Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) [-] [-] ₹[-]
Retail (Max) [-] [-] ₹[-]
S HNI (Min) [-] [-] ₹[-]
S HNI (Max) [-] [-] ₹[-]
B HNI (MIN) [-] [-] ₹[-]

Molbio Diagnostics Limited IPO registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222
Email Id molbio.ipo@kfintech.com
Website www.kfintech.com

Molbio Diagnostics Limited IPO Lead Manager

1. Kotak Mahindra Capital Company Limited

2. IIFL Capital Services Limited

3. Jefferies India Private Limited

4. Motilal Oswal Investment Advisors Limited

Molbio Diagnostics Limited Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹968.39 Cr ₹823.38 Cr ₹721.48 Cr
Reserves and Surplus ₹966.14 Cr ₹821.13 Cr ₹719.22 Cr
Total Borrowing ₹123.16 Cr ₹174.58 Cr ₹108.44 Cr

Molbio Diagnostics Limited IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 0 0 0
Non Institutional Investors (NIIs) 0 0 0
Retail Individual Investors (RIIs) 0 0 0
Total 0 0 0

Strength of Molbio Diagnostics Limited

  • We are well placed to address unmet demand in a large and growing molecular diagnostic market with gaining credence of point-of-care testing
  • Our strong R&D capabilities and track record of developing innovative diagnostic products
  • We have developed and commercialized a novel portable multi-disease point-of-care molecular diagnostics platform
  • We have a scalable business model with strong entry barriers, high proportion of recurring revenues and a growing suite of tests
  • Our strategic collaborations and acquisitions enhance our capabilities and offerings
  • We have a management team with deep domain expertise and track record of delivering strong financial performance

Risks Involved

  • The company derives a significant portion of its revenues from the sale of the company's products to the Indian central and state governments, and international aid agencies for their public healthcare programs. The company's revenue from such government and international aid agencies was 87.83%, 91.60% and 78.39% of its revenue from contracts with customers - sale of products - finished goods in Fiscals 2025, 2024 and 2023, respectively. Any unfavourable policy changes by these agencies or a decrease in funding for public healthcare programs may impact the sale of the company's products and adversely affect its business, financial condition, results of operations and cash flows.
  • The company derives a significant portion of its revenues from the sale of diagnostic test kits for tuberculosis ("TB"). The company's revenue from the sale of test kits for TB was 69.11%, 62.40% and 41.56% of its revenue from contracts with customers - sale of products - finished goods in Fiscals 2025, 2024 and 2023, respectively. Any decline in the demand for such test kits may have an adverse effect on the company's business, financial condition, results of operation and cash flows.
  • The company derives a significant portion of its revenue from the company's top 10 customers. The company's revenue from the top 10 customers was 83.62%, 78.54% and 66.07% of its revenue from contracts with customers - sale of products - finished goods in Fiscals 2025, 2024 and 2023, respectively. The loss of any of these customers or a decline in demand for our products from them could have an adverse effect on the company's business, financial condition, results of operations and cash flows.
  • The company has invested and intend to continue to invest in research and development ("R&D") efforts to grow its menu of tests. The company cannot assure you that our R&D efforts will result in the successful development and obtaining of government approvals for new tests, which could adversely affect the company's business, results of operations, and cash flows.
  • The company incurred losses in Fiscal 2023 and the company may incur losses in the future.
  • The company's sales cycle and sales demand are variable, which makes it difficult for the company to forecast its business, results of operations, financial condition and cash flows.
  • The company's inability to accurately forecast demand for its products and manage the company's inventory may have an adverse effect on its business, financial condition, results of operations and cash flows.
  • Any product liability claims or regulatory actions or imposition of liquidated damages on account of the company's failures to meet the contractual obligations, could have an adverse effect on its business, results of operations, financial condition and cash flows.
  • The company's operations are subject to extensive government regulation and if the company fails to obtain, maintain or renew the company's statutory and regulatory licenses, permits and approvals required to operate its business, results of operations and cash flows may be adversely affected.
  • The company's Statutory Auditor's reports on internal financial controls issued on its audited consolidated financial statements for Fiscals 2023 and 2024 contain a disclaimer of opinion relating to the Statutory Auditors' inability to obtain appropriate audit evidence to provide a basis for opinion on adequate internal financial controls.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Striders Impex Limited IPO
Bidding Period
26th Feb 2026 - 3rd Mar 2026
Price Range
₹71.0 - 72.0
IPO Size
₹36,29,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹75.0 - 79.0
IPO Size
₹1,65,00,00,000
MANILAM INDUSTRIES INDIA LIMITED IPO
Bidding Period
20th Feb 2026 - 2nd Feb 2026
Price Range
₹65.0 - 69.0
IPO Size
₹40,00,00,000
FRACTAL INDUSTRIES LIMITED IPO
Bidding Period
16th Feb 2026 - 2nd Feb 2026
Price Range
₹205.0 - 216.0
IPO Size
₹49,00,00,000
MARUSHIKA TECHNOLOGY LIMITED IPO
Bidding Period
12th Feb 2026 - 2nd Feb 2026
Price Range
₹111.0 - 117.0
IPO Size
₹27,00,00,000
FRACTAL ANALYTICS LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹857.0 - 900.0
IPO Size
₹28,34,00,00,000
AYE FINANCE LIMITED IPO
Bidding Period
9th Feb 2026 - 2nd Feb 2026
Price Range
₹122.0 - 129.0
IPO Size
₹10,10,00,00,000
BIOPOL CHEMICALS LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹102.0 - 108.0
IPO Size
₹31,00,00,000
PAN HR SOLUTION LIMITED IPO
Bidding Period
6th Feb 2026 - 2nd Feb 2026
Price Range
₹74.0 - 78.0
IPO Size
₹17,00,00,000
NFP SAMPOORNA FOODS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
BRANDMAN RETAIL LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹167.0 - 176.0
IPO Size
₹86,00,00,000
GROVER JEWELLS LIMITED IPO
Bidding Period
4th Feb 2026 - 2nd Feb 2026
Price Range
₹83.0 - 88.0
IPO Size
₹34,00,00,000
C K K RETAIL MART LIMITED IPO
Bidding Period
30th Jan 2026 - 2nd Feb 2026
Price Range
₹155.0 - 163.0
IPO Size
₹88,00,00,000
ACCRETION NUTRAVEDA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹122.0 - 129.0
IPO Size
₹25,00,00,000
MSAFE EQUIPMENTS LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹116.0 - 123.0
IPO Size
₹66,00,00,000
KANISHK ALUMINIUM INDIA LIMITED IPO
Bidding Period
28th Jan 2026 - 1st Jan 2026
Price Range
₹73.0 - 73.0
IPO Size
₹29,00,00,000
KASTURI METAL COMPOSITE LIMITED IPO
Bidding Period
27th Jan 2026 - 1st Jan 2026
Price Range
₹61.0 - 64.0
IPO Size
₹18,00,00,000
HANNAH JOSEPH HOSPITAL LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹67.0 - 70.0
IPO Size
₹42,00,00,000
SHAYONA ENGINEERING LIMITED IPO
Bidding Period
22nd Jan 2026 - 1st Jan 2026
Price Range
₹140.0 - 144.0
IPO Size
₹15,00,00,000
KRM AYURVEDA LIMITED IPO
Bidding Period
21st Jan 2026 - 1st Jan 2026
Price Range
₹128.0 - 135.0
IPO Size
₹77,00,00,000
SHADOWFAX TECHNOLOGIES LIMITED IPO
Bidding Period
20th Jan 2026 - 1st Jan 2026
Price Range
₹118.0 - 124.0
IPO Size
₹19,07,00,00,000
  • All
  • MainBoard
  • SME
FRACTAL INDUSTRIES LIMITED IPO
Issue Prize
216.00
Listing Day Close
217.55(0.93%)
MARUSHIKA TECHNOLOGY LIMITED IPO
Issue Prize
117.00
Listing Day Close
114.00(-2.56%)
FRACTAL ANALYTICS LIMITED IPO
Issue Prize
900.00
Listing Day Close
847.40(-5.89%)
AYE FINANCE LIMITED IPO
Issue Prize
129.00
Listing Day Close
128.90(0.00%)
BIOPOL CHEMICALS LIMITED IPO
Issue Prize
108.00
Listing Day Close
105.50(-1.85%)
PAN HR SOLUTION LIMITED IPO
Issue Prize
78.00
Listing Day Close
78.01(0.00%)
BRANDMAN RETAIL LIMITED IPO
Issue Prize
176.00
Listing Day Close
192.15(9.09%)
GROVER JEWELLS LIMITED IPO
Issue Prize
88.00
Listing Day Close
100.80(14.77%)
C K K RETAIL MART LIMITED IPO
Issue Prize
163.00
Listing Day Close
171.15(4.91%)
ACCRETION NUTRAVEDA LIMITED IPO
Issue Prize
129.00
Listing Day Close
191.20(48.06%)
MSAFE EQUIPMENTS LIMITED IPO
Issue Prize
123.00
Listing Day Close
150.30(21.95%)
KANISHK ALUMINIUM INDIA LIMITED IPO
Issue Prize
73.00
Listing Day Close
55.48(-24.66%)
KASTURI METAL COMPOSITE LIMITED IPO
Issue Prize
64.00
Listing Day Close
63.16(-1.56%)
HANNAH JOSEPH HOSPITAL LIMITED IPO
Issue Prize
70.00
Listing Day Close
68.25(-2.86%)
SHAYONA ENGINEERING LIMITED IPO
Issue Prize
144.00
Listing Day Close
151.00(4.86%)
KRM AYURVEDA LIMITED IPO
Issue Prize
135.00
Listing Day Close
180.70(34.07%)
SHADOWFAX TECHNOLOGIES LIMITED IPO
Issue Prize
124.00
Listing Day Close
109.90(-11.29%)
DIGILOGIC SYSTEMS LIMITED IPO
Issue Prize
104.00
Listing Day Close
79.05(-24.04%)
ARITAS VINYL LIMITED IPO
Issue Prize
47.00
Listing Day Close
44.65(-4.26%)
ARMOUR SECURITY INDIA LIMITED IPO
Issue Prize
57.00
Listing Day Close
43.35(-24.56%)

Frequently Asked Questions

What is Molbio Diagnostics Limited IPO?

Answer Field

Molbio Diagnostics Limited IPO is a IPO of [-] equity shares of a face value of ₹[-] aggregating up to ₹[-] Crores. The issue is priced at ₹[-] to ₹[-] per share. The minimum order quantity is [-] Shares. The IPO opens on [-], and closes on [-]. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on .

When Molbio Diagnostics Limited IPO will open?

Answer Field

The Molbio Diagnostics Limited IPO opens on [-] and closes on [-].

What is the lot size of Molbio Diagnostics Limited?

Answer Field

Molbio Diagnostics Limited lot size is [-] shares, and the minimum amount required is ₹[-].

How to apply for Molbio Diagnostics Limited IPO?

Answer Field

You can apply in Molbio Diagnostics Limited IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Molbio Diagnostics Limited IPO allotment?

Answer Field

The finalization of Basis of Allotment for Molbio Diagnostics Limited IPO will be done on [-], and the allotted shares will be credited to your demat account by [-].

When is Molbio Diagnostics Limited IPO listing date?

Answer Field

The Molbio Diagnostics Limited listing date is [-].

Who is the registrar of Molbio Diagnostics Limited IPO?

Answer Field

The registrar of Molbio Diagnostics Limited IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Limited,IIFL Capital Services Limited,Jefferies India Private Limited,Motilal Oswal Investment Advisors Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Molbio Diagnostics Limited IPO?

Answer Field

The fresh issue size is ₹[-] Crores equity shares.

What minimum lot size can retail subscribers subscribe to Molbio Diagnostics Limited?

Answer Field

Retail investors can subscribe to a minimum of one lot, [-] shares and ₹[-] amount.

How can I approve the UPI mandate request for Molbio Diagnostics Limited IPO?

Answer Field

To apply for Molbio Diagnostics Limited IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Molbio Diagnostics Limited?

Answer Field

The price of each Molbio Diagnostics Limited share will be ranging in between ₹[-] to ₹[-] per share.

What is the cut-off time for the UPI mandate for Molbio Diagnostics Limited IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, [-].

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|